[3-step test for screening potential cancerostatics. 1. Screening program and results of the 1st step].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001391:Azo Compounds / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004987:Ethers; D006834:Hydrazines / Q000494:pharmacology; D007942:Leukemia, Experimental / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D051379:Mice; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013844:Thiazoles / Q000494:pharmacology
D000970:Antineoplastic Agents; D001391:Azo Compounds; D001562:Benzimidazoles; D004987:Ethers; D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D011687:Purines; D013844:Thiazoles
3-Stufentest als Scrrening-Programm für potentielle Cancerostatica. 1. Das Screening-Programm und Ergebnisse der I. Teststufe.